SGA
CRNX

Sector Gamma AS’s Crinetics Pharmaceuticals CRNX Stock Holding History

Sector Gamma AS’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.29M Buy
114,628
+20,433
+22% +$760K 0.93% 34
2026
Q1 		$3.42M Sell
94,195
-20,805
-18% -$929K 0.81% 33
2025
Q4 		$5.35M Buy
+115,000
New +$5.12M 1.22% 27

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JT
Jupiter Topco New York $245B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sector Gamma AS's CRNX Position: Q2 2026 in Review

Sector Gamma AS increased its Crinetics Pharmaceuticals (CRNX) stake by 22% in Q2 2026, buying an estimated $760K and bringing the position to 114,628 shares worth $4.29M. The position accounts for 0.93% of the portfolio, ranked #34.

Sector Gamma AS first reported a position in CRNX in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.35M in Q4 2025. 267 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

  • Sector Gamma AS held 114,628 shares of Crinetics Pharmaceuticals worth $4.29M as of Q2 2026.
  • Sector Gamma AS bought 20,433 Crinetics Pharmaceuticals shares in Q2 2026, an estimated $760K.
  • Crinetics Pharmaceuticals made up 0.93% of Sector Gamma AS's portfolio in Q2 2026, its #34 holding.
  • Sector Gamma AS first reported a position in Crinetics Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Sector Gamma AS's Crinetics Pharmaceuticals position peaked at $5.35M in Q4 2025.
  • 267 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on Sector Gamma AS's 13F filing for Q2 2026, filed 12 Aug 2026.